CPRX - 3.14 Pre-market now at 3.73/3.74 Catalyst Pharmaceutical Q1 EPS $(0.01) Beats $(0.13) Estimate, Sales $12.448M Beat $1.6M Estimate Catalyst Pharmaceuticals Expects Top-Line Results From Phase 3 Trial for MuSK-MG in 2H of 2019 >CPRX https://www.tradescores.com/StockReport/cprx